No insider purchase over the last 90 days. The latest, by Mahai Chris LaVictoire, was filed 20 Jul 2026.
Who traded when
BuySaleSince the insiders bought
- -4.8%Entry US$24.25 · Close at T+90 US$23.09
- -21.0%Entry US$21.42 · Close at T+365 US$16.93
- +1.2%Entry US$18.97 · Close at T+365 US$19.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended September 2025 · cache
- 568 shares@ US$18.490.0013% mcap100.0% of flowCommon StockSEC:0001104659-26-085023:0Canonical exit: 14 Oct 2026 (T+90)
- 1,000 shares@ US$21.30100.0% of flowCommon StockSEC:0001104659-24-080800:0Canonical exit: 14 Oct 2024 (T+90)
- 600 shares@ US$19.5381100.0% of flowCommon StockSEC:0001104659-24-046550:0Canonical exit: 8 Jul 2024 (T+90)
- 1,000 shares@ US$18.436100.0% of flowCommon StockSEC:0001104659-24-001274:0Canonical exit: 1 Apr 2024 (T+90)
- 1,000 shares@ US$18.25100.0% of flowCommon StockSEC:0001104659-24-000361:0Canonical exit: 27 Mar 2024 (T+90)
- 69.188 shares@ US$21.68512.9% of flowShares of Beneficial InterestSEC:0001104659-22-037467:0Canonical exit: 21 Jun 2022 (T+90)
- 479 shares@ US$21.7387.1% of flowShares of Beneficial InterestSEC:0001104659-22-008201:0Canonical exit: 26 Apr 2022 (T+90)
- 1,196 shares@ US$20.85100.0% of flowShares of Beneficial InterestSEC:0001104659-21-030170:0Canonical exit: 26 May 2021 (T+90)
- 570 shares@ US$17.68100.0% of flowShares of Beneficial InterestSEC:0001104659-20-107791:0Canonical exit: 22 Dec 2020 (T+90)
- 7,300 shares@ US$14.67100.0% of flowShares of Beneficial InterestSEC:0001104659-20-034867:0Canonical exit: 15 Jun 2020 (T+90)
- 6,000 shares@ US$17.4320.3% of flowShares of Beneficial InterestSEC:0001104659-18-063921:0Canonical exit: 23 Jan 2019 (T+90)
- 5,902 shares@ US$18.1920.7% of flowShares of Beneficial InterestSEC:0001104659-18-062504:0Canonical exit: 15 Jan 2019 (T+90)
- 5,500 shares@ US$17.5918.5% of flowShares of Beneficial InterestSEC:0001104659-18-061572:0Canonical exit: 9 Jan 2019 (T+90)
- 5,500 shares@ US$18.2719.3% of flowShares of Beneficial InterestSEC:0001104659-18-061368:0Canonical exit: 8 Jan 2019 (T+90)
- 1,400 shares@ US$18.50100.0% of flowShares of Beneficial InterestSEC:0001728564-18-000007:0Canonical exit: 25 Apr 2018 (T+90)
- 1,000 shares@ US$20.07Shares of Beneficial InterestSEC:0001104659-14-084860:0Canonical exit: 3 Mar 2015 (T+90)
- 1,000 shares@ US$20.00Shares of Beneficial InterestSEC:0001104659-14-054468:0Canonical exit: 26 Oct 2014 (T+90)
- 5,000 shares@ US$20.00Shares of Beneficial InterestSEC:0001104659-14-054467:0Canonical exit: 26 Oct 2014 (T+90)
18 of 18 declarations
About abrdn Healthcare Opportunities Fund
All 15 filings at abrdn Healthcare Opportunities Fund are purchases, worth EUR 585,009 in total with a median of EUR 19,537, and there is no sale. They run from January 29, 2018 to July 20, 2026, for a fund classed in the Finance & Banking sector and valued at USD 775.3 million.
Daniel R. Omstead (President) filed 5 of them. The largest purchases date from 2018 and 2020: EUR 95,932 on March 17, 2020, EUR 93,347 on October 17, 2018 and EUR 91,915 on October 25, 2018. Kathleen Goetz (Director) filed 3, and Chris LaVictoire Mahai, Rose DiMartino and Todd Reit (all Director) one each. Between December 28, 2023 and January 2, 2024, 2 filers bought EUR 33,130.
Read moreShow less
Activity is sparse: 5 filings in 2018, 2 in 2020, 1 in 2021, 2 in 2022, 4 in 2024 and 1 in 2026. All 15 purchases have a stored 90-day result: median 1.2%, 60% positive (past stored results, not a forecast). The last twelve months hold one filing, a purchase. The median publication delay is 1 day.
